Does TECLISTAMAB Cause Multiple organ dysfunction syndrome? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Multiple organ dysfunction syndrome have been filed in association with TECLISTAMAB (TECVAYLI). This represents 1.9% of all adverse event reports for TECLISTAMAB.
23
Reports of Multiple organ dysfunction syndrome with TECLISTAMAB
1.9%
of all TECLISTAMAB reports
22
Deaths
22
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From TECLISTAMAB?
Of the 23 reports, 22 (95.7%) resulted in death, 22 (95.7%) required hospitalization, and 17 (73.9%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Plasma cell myeloma (100)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which TECLISTAMAB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR